Vijayaditya Agri Biotech

Country/Region: India     State/Province: New Delhi

Main Products: Solanesol, Solanesol

Company Introduction
In the most revolutionizing industry Vijayaditya Agri Biotech Corporation Limited Liability Company has reached a milestone owing to the top notch production facility with technologically advanced equipment to manufacture first in class Solanesol, committing reliability, durability and optimum functioning. Since our inception, back in 2013 we have designed products to provide electrical solution having no match because we only source raw material that caters to durability, safety and meets international standards. Our export operations invaded international market as well, now holding Australia,Canada,Germany,Netherlands,United Kingdom export market share with gross export ratio value of US$10 Million - US$50 Million. Products we count on include Solanesol, helping us generate overall annual revenue across Approx 5 Million US Dollar. Electronic products in the market never go out of demand and to successfully meet that, our production potential is always on point, thanks to our manufacturing facility with Own Lisence, situated in NEW DELHI, , India.As a leading Manufacturer and Retailer, we hold export history of 7 Years , covering a milestone from where we began first with initial business capital of Above US$100 Million.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2013, 2013

Legal Status: Own Lisence

Ownership: Corporation Limited Liability Company

Employees: 501 - 1000 People

Factory Size: 1, 000-3, 000 square meters

R&D Team Size: 5 - 10 People

Certifications: FSC

Contact Information

Contact Person: raj

Designation: Marketing

Department: Managing Partner

Telephone: 91918647000000

Business Information

Main Markets: United Kingdom (18%) Germany (18%) Australia (18%) Canada (16%) Netherlands (15%)

Export Focus: Australia, Canada, Germany, Netherlands, United Kingdom

Contract Services: Buyer Label Offered

Trade & Financial Information

Annual Revenue: Approx 5 Million US Dollar

Registered Capital: Above US$100 Million

Export Percentage: 71% - 80%

Payment Terms: Bank wire (T/T)

Product Showcase
Solanesol
Solanesol

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Medicines in India Medicines in New Delhi Solanesol in India Solanesol in New Delhi